The mechanism of development of microangiopathy is incompletely understood, but relates to a number of ultrastructural, biochemical and haemostatic processes. These include capillary basement membrane thickening, non-enzymatic glycosylation, possibly increased free rad ical activity, increased flux through the polyol pathway and haemostatic abnormalities. The central feature appears to be hyperglycaemia, which is causally related to the above processes and culminates in tissue ischaemia. This article will briefly describe these processes and will discuss possible pathogenic interactions which may lead to the development of the pathological lesion.
Eye (1993) 7, 218-222 its glycosidally linked disaccharide units. Such alterations lead to abnormal packing of the peptide chains producing excessive leakiness of the membrane. The exact mech anisms of thickening and leakiness of basement mem brane and their relevance to diabetic complications are not entirely clear, but appear to involve several biochemical mechanisms.
Non-enzymatic Glycosylation
In the presence of persistent hyperglycaemia glucose chemically attaches to proteins non-enzymatically to form a stable product (keto amine or Amadori product) of which glycosylated haemoglobin is the best-known example. In long-lived tissue proteins such as collagen the ketoamine then undergoes a series of reactions resulting in the development of advanced glycosylation end products (AGE) (Fig. 1) .5 AGE are resistant to degradation and con tinue to accumulate indefinitely on long-lived proteins. They are qualitatively identified by their characteristic brown pigment fluorescence ('protein browning') and participation in protein cross-linking.6 This could lead to trapping of albumin and immunoglobulin G within base ment membrane.7 One study has reported a significant relationship between collagen browning and microangio pathy in skin biopsies from patients with insulin-depend ent (type 1) diabetes mellitus, where AGE-corrected fluorescence was related to the severity of retinopathy, nephropathy and arterial and joint stiffness.8
Protein Fluorescence, Free Radical Activity and Antioxidant Status
Fluorescence of long-lived non-enzymatically glycosy lated proteins may not be entirely due to glycosylation per se. Free radicals, which are violently reactive chemical species having unpaired electron spins, will also induce oxidation of protein amino acid residues as well as lipid peroxidation. The former process leads directly to both protein cross-linking and fluorescence due to the forma tion of kynurenines , from aromatic amino acid residues.9-11 In addition, non-enzymatic glycosylation of serum protein confers an increased susceptibility to free-radical-induced protein fluorescence and aggregation. 1 2 Increased free radical activity in diabetes is suggested from studies examining lipid peroxidation. There are reports of increased lipid peroxidation in diabetes particu larly in relation to microangiopathy. 13-\5 Both free radicals Aldose reductase 219 and their lipid hydroperoxide products may be directly cytotoxic to vascular endothelial cells. 16 Apart from their direct cytotoxic effect, lipid hydroperoxides stimulate cyclooxygenase and hence prostaglandin synthesis while at the same time inhibiting prostacyclin production. [16] [17] [18] Free radicals are produced continuously during many metabolic processes and are rapidly eliminated by anti oxidants such as reduced glutathione (GSH) and vitamins C and E. Diabetic patients, however, have lower concen trations of GSH, ascorbate and vitamin E.19-22 The reduc tion in antioxidant reserve in diabetic patients may be due to competition for NADPH, which is a co-factor required to recycle the oxidised free radical scavengers back to the effective reduced form (,redox cycling'). NADPH is pro duced for the hexose monophosphate shunt and one source of competition from NADPH comes from the sor bitol pathway.
Sorbitol (Polyol) Pathway
The sorbitol or polyol pathway converts glucose to sorbi tol and has been implicated in the pathogenesis of many diabetic complications (Fig. 2 ). 2 3 In animal studies inhibi tion of aldose reductase has been shown to prevent micro angiopathy 2 4-2 6 although results in humans have been disappointing. 2 7 The mechanism of action of aldose reduc tase inhibitors in these studies is unclear, but appears to be unrelated to the osmotic stress hypothesis of intracellular sorbitol accumulation. 2 8 It is possible that increased flux through the pol yo I pathway causes increased NADPH utilisation resulting in less NADPH being available 2 9 for conversion of antioxidants back to their free-radical-scav enging reduced form. This increased utilisation of NADPH may render the tissues less able to deal with oxi dative stress.
Protein Kinase C Activity
Hyperglycaemia is associated with increased cellular pro tein kinase C activity in cultured endothelial cells, result ing from enhanced synthesis of diacylglycerol from glucose.3o Protein kinase C is involved in signal trans duction of responses to hormones, growth factors and neurotransmitters. It can modify growth rate, DNA syn thesis, hormone receptor turnover and contraction in vas cular smooth muscle cells. It may have a role in the development of microangiopathy in relation to hyper glycaemia, but such a role needs detailed clarification.
Sorbitol dehydrogenase
Glucose Endothelial Cells and Abnormalities of increased in platelets taken from patients with vascular Haemostasis complications34.35 and this agent is a potential vasoconFactor VIII produced in the endothelial cell is increased in strictor and causes platelet aggregation. The platelets also patients with early diabetic retinopathy,3! a situation carry powerful mediators of the microcirculation such as which would promote microthrombus formation. Prosserotonin and platelet derived growth factors.36.37 tacyclin (PGI 2 ) is also produced in the endothelial cell and Increased platelet aggregation is well described in diais a powerful vasodilator which antagonises platelet betics on the basis of measuring proteins released from the aggregation and platelet adherence to the vascular wall. platelet on aggregation (e.g. �-thromboglobulin and plateStudies have shown decreased PGI 2 production from vaslet factor 4).38.39 Both techniques have detected increased cular walls in animal models3 2 and reduced circulating platelet reactivity in diabetic microangiopathy. PGI 2 in diabetic patients?! Plasminogen activator, which The combination offeduced endothelial cell production converts plasminogen to plasmin acting to promote fibrinof PGI 2 and the activators of fibrinolysis, together with olysis, has also been reported to be low in diabetes. 33 increased platelet reactivity and increased factor VIII proThe above abnormalities are mirrored by abnormalities duction, produces a thrombotic tendency. This leads to in platelet function in diabetes. Thromboxane A 2 release is microthrombus formation and small vessel occlusion and thus contributes to the abnormalities of blood flow in the small vessels.
PATHOGENIC INTERACTIONS
Possible pathogenic interactions are summarised in Fig. 3 . The hypothesis suggests that hyperglycaemia is central, leading to excessive utilisation of NADPH via the polyol pathway and non-enzymatic glycosylation. Advanced glycosylation end products forming from long-lived tissue proteins, either spontaneously or from excess free radical formation, trap potentially damaging immunoglobulins and complement components. Excess free radicals may be produced either from protein glycation or because of inef ficient elimination by reduced antioxidants, possibly secondary to NADPH utilisation and defective redox cycling. Endothelial cell dysfunction and damage, and increased platelet aggregation produced as a consequence of the above, further contribute to a vicious circle with release of factors such as TXA 2 and factor VIII. The sequence culminates in CBMT, microthrombus formation and tissue ischaemia. These factors together with haemo dynamic abnormalities, genetic susceptibility, hyper tension and perhaps insulin-like growth factors result in the microvascular changes seen in susceptible target organs.
CONCLUSIONS
The mechanism of development of microangiopathy is likely to be complex, involving a number of different bio chemical pathways. Increased knowledge of these path ways allows hypotheses to be constructed which can be tested. Further understanding of pathogenesis will suggest a number of therapeutic approaches which may lead in the future to important therapeutic options.
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